| abstract |
The present invention relates to the use of an alkaline or alkaline earth metal chondroitin sulphate, which comes from an enzymatic hydrolysis of anim al cartilage, for the preparation of a medicament for the treatment or preventi on of psoriasis with skin affection in a mammal. Preferably the sodium chondroitin sulphate has an average molecular weight between 10,000 and 20,0 00 daltons, and is administered orally. |